Skip to main content
. 2021 Mar 1;38(2):141–142. doi: 10.4274/balkanmedj.galenos.2020.2020.9.106

FIG. 1. a, b.

FIG. 1. a, b

The appearance of the lesions after the interruption of ibrutinib treatment. Mass lesion over the left orbit (a) and left hard palate (b).